KPV

Description

KPV (Ac-KPV-NH₂) is a highly targeted anti-inflammatory peptide derived from alpha-melanocyte-stimulating hormone (α-MSH) that has gained significant attention in biomedical research for its potent immunomodulatory activity. This short but powerful peptide sequence has demonstrated broad potential across multiple inflammatory conditions, positioning it as one of the most promising compounds in inflammation-focused peptide research.

One of the most active and exciting areas of investigation for KPV is inflammatory bowel disease (IBD). In preclinical and laboratory studies, Ac-KPV-NH₂ has shown encouraging effects in reducing intestinal inflammation, supporting gut barrier integrity, and calming overactive immune responses commonly associated with chronic digestive disorders. These properties have made it a compound of strong interest for researchers exploring new therapeutic approaches for Crohn’s disease, ulcerative colitis, and related inflammatory conditions.

Beyond gastrointestinal research, Ac-KPV-NH₂ has also demonstrated compelling potential in the field of wound care and tissue repair. Studies involving KPV and other α-MSH–derived peptides suggest benefits that go well beyond basic inflammation control. Research has indicated that this class of peptides may help accelerate wound healing, reduce microbial burden, and improve overall tissue quality during recovery. By modulating inflammatory signaling and supporting the skin’s natural repair processes, KPV contributes to faster closure, reduced irritation, and potentially improved cosmetic outcomes.

The peptide’s effects on immune regulation and tissue response have also placed it under investigation for surgical recovery and scar management research. Early findings indicate that KPV may help reduce excessive inflammation and fibrosis, two major factors that contribute to scarring. This has raised interest in its future potential as a supporting compound for post-surgical tissue appearance and healing efficiency.

While continued clinical research is needed to fully validate long-term applications, Ac-KPV-NH₂ stands out as a next-generation peptide with broad regenerative promise. Its versatility across gastrointestinal research, wound healing science, and immune modulation reflects its potential importance in the future of peptide-based therapeutics.

Comes in 14mg vial

Provided as lyophilized powder intended strictly for experimental and research applications.